RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY;CELLCEUTIX CORPORATION
发明人:
SCOTT, RICHARD W.,FREEMAN, KATIE,TANG, HAIZHONG,DIAMOND, GILL
申请号：
CA2862170
公开号：
CA2862170A1
申请日:
2013.01.18
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present disclosure provides facially arnphiphilic antimicrobial oligomers, pharmaceutically acceptable salts thereof, or a pharmaceutical composition thereof, useful for killing or inhibiting the growth of a Candida or Aspergillus species, as well as preventing or treating a mammal having oral or disseminated candidiasis or an aspergillus infection. The method(s) employed comprise(s) contacting the Candida or Aspergillus species with or administering to the mammal in need thereof an effective amount of such an antimicrobial oligomer, pharmaceutically acceptable salts thereof, or a pharmaceutical composition thereof.
